LUNA Luna Innovations Incorporated

Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing, instrumentation and nanotechnology, today announced its financial results for the second quarter and six months ended June 30, 2010.

As compared to the same quarter last year, total revenue increased by 4%, from $8.7 million in the second quarter of 2009 to $9.0 million in the second quarter of 2010, driven by a 31% revenue increase in the company’s product and license segment, from $2.2 million in the second quarter of 2009 to $2.9 million in the second quarter of 2010. Operating expenses improved by $1.8 million, or 32%, due to the non-recurring costs incurred for litigation and reorganization activities in 2009, in addition to on-going expense savings initiatives. The company reported a net loss attributable to common stockholders of $0.7 million, or $0.05 per common share, for the second quarter of 2010, as compared to a net loss of $2.4 million, or $0.21 per common share for the second quarter of 2009. Adjusted EBITDA, which is earnings before interest, taxes, depreciation and amortization, excluding non-cash stock-based compensation expense, non-cash charges for impairment of intangible assets and charges related to the company’s litigation with Hansen Medical, Inc. and its Chapter 11 reorganization, improved to $0.8 million for the second quarter of 2010, as compared to $0.5 million for the second quarter of 2009.

Dale Messick, Interim President and Chief Operating Officer, provided this overview of Luna’s results: “Continued growth in our fiber optic test & measurement products has resulted in our return to year over year revenue growth overall. Along with this growth, we continue to be very pleased with the progress we are making in our bottom line results, adjusted EBITDA and cash flows now that the Hansen litigation and reorganization are behind us. Our adjusted EBITDA excluding litigation and reorganization-related items improved 80% compared to the second quarter of last year. Our net cash used in operating activities of $1.7 million for the first half of the year includes the impact of payment of approximately $1.9 million in pre-petition liabilities from the 2009 reorganization and related legal fees, absent which cash from operating activities would have been slightly positive for the first half of the year.”

Second Quarter Financial Highlights

-- Total revenues increased by 4%, from $8.7 million for the second quarter of 2009 to $9.0 million for the second quarter of 2010.

-- Product and license revenues increased by 31% to approximately $2.9 million for the second quarter of 2010 from $2.2 million for the second quarter of 2009. Technology development revenues decreased by 6% to $6.1 million for the second quarter of 2010 from $6.5 million for the second quarter of 2009.

-- Gross profit for the second quarter of 2010 of $3.3 million was consistent with the gross profit realized in the second quarter of 2009.

-- Selling, general and administrative expenses decreased by 32% to $3.4 million, or 37% of total revenues for the second quarter of 2010, from $4.9 million, or 57% of total revenues, for the second quarter of 2009, driven by a reduction in litigation-related expenses.

-- Total operating expenses decreased to $3.8 million, or 42% of total revenues for the second quarter of 2010, from $5.6 million, or 65% of total revenues, for the second quarter of 2009.

-- Adjusted EBITDA excluding litigation and reorganization-related items increased to $0.8 million in the second quarter of 2010 from $0.5 million in the second quarter of 2009.

-- Net loss attributable to common stockholders improved to $0.7 million for the second quarter of 2010, compared to a net loss attributable to stockholders of $2.4 million for the second quarter of 2009.

-- Cash and cash equivalents totaled $6.3 million at June 30, 2010, as compared to $12.1 million at June 30, 2009 and $5.2 million at December 31, 2009. At June 30, 2010, $2.5 million continued to be outstanding under the company’s revolving line of credit.

-- Sales of fiber optic test & measurement, sensing and instrumentation products increased 42% from $1.4 million in the second quarter of 2009 to $2.0 million in 2010.

-- Launched the portable Optical Backscatter Reflectometer™(OBR) 4200 in the second quarter with potential applications in areas including telecommunications, medical imaging, aircraft and shipboard network verification.

Outlook for 2010

Based on information as of August 10, 2010, the company is lowering its guidance for the year due to a decline in the rate and timing of new contract awards in our Technology Development business segment. The company expects a net loss for the year in the range of $3.0 million to $4.0 million compared to its previous guidance of $2.8 million to $3.5 million. The company expects a revenue range of $33 million to $35.5 million; lowering its Technology Development revenue to be in the range of $23.0 to $24.0 million for the year and increasing its expectations on the product and license revenue of $10.0 million to $11.5 million for the full year. For the third quarter of 2010, the company expects revenue of approximately $8.5 million to $9.5 million and a net loss of approximately $0.5 million to $1.0 million.

Non-GAAP Measures

In evaluating the operating performance of its business, Luna’s management excludes certain charges and credits that are required by generally accepted accounting principles (“GAAP”). These non-GAAP results provide useful information to both management and investors by excluding items that the company believes may not be indicative of its operating performance, because either they are non-cash items or they are unusual items that the company does not expect to recur in the ordinary course of its business or are unrelated to the ongoing operation of the business in the ordinary course. These non-GAAP measures should be considered in addition to results and guidance prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. The non-GAAP measures included in this press release have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.

Conference Call Information

As previously announced, Luna Innovations will conduct an investor conference call at 5:00 p.m. (EDT) today to discuss its financial results and business developments for the second quarter of 2010. The call can be accessed by dialing 866.711.8198 domestically or 617.597.5327 internationally prior to the start of the call. The access code is 36809820. Investors are advised to dial in at least five minutes prior to the call to register. The conference call will also be webcast live over the Internet. The webcast can be accessed by logging on to the “Investor Relations” section of the Luna Innovations website, http://www.lunainnovations.com, prior to the event. The webcast will be archived under the “Webcasts and Presentations” section of the Luna Innovations website for at least 30 days following the conference call.

About Luna Innovations:

Luna Innovations Incorporated (www.lunainnovations.com) is focused on sensing and instrumentation, and pharmaceutical nanomedicines. Luna develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. The company’s products are used to measure, monitor, protect and improve critical processes in the markets we serve. Through its disciplined commercialization business model, Luna has become a recognized leader in transitioning science to solutions. Luna is headquartered in Roanoke, Virginia.

Forward Looking Statements:

The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include our expectations regarding financial results for the third quarter and full year 2010 and applications for the Company’s OBR product. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of the Company may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation the fact that the outlook for the third quarter of and full year 2010 could change, and also include, without limitations, those risks and uncertainties set forth in the Company’s periodic reports and other filings with the Securities and Exchange Commission. Such filings are available at the SEC’s website at http://www.sec.gov, and at the company’s website at http://www.lunainnovations.com. The statements made in this release are based on information available to the company as of the date of this release and Luna Innovations undertakes no obligation to update any of the forward-looking statements after the date of this release.

 

       

Luna Innovations Incorporated Consolidated Statements of Operations

 

 

Six Months Ended

June 30,

 

June 30,

2010

2009

2010

2009

(unaudited)

(unaudited)

Revenues: Technology development revenues $ 6,091,503 $ 6,446,971 $ 11,902,597 $ 13,329,343 Product and license revenues   2,907,139   2,214,808   4,981,836   3,825,991   Total revenues 8,998,642 8,661,779 16,884,433 17,155,334   Cost of revenues: Technology development costs 4,192,920 4,271,252 8,025,260 9,169,008 Product and license costs   1,499,861   1,048,249   2,719,102   1,926,850   Total cost of revenues   5,692,781   5,319,501   10,744,362   11,095,858   Gross Profit 3,305,861 3,342,278 6,140,071 6,059,476 Operating expense: Selling, general and administrative 3,350,524 4,907,564 6,765,036 9,142,073 Research, development, and engineering 430,181 684,755 946,809 1,681,475 Litigation reserve - - - 36,303,643 Impairment of intangible assets   -   -   -   1,310,598   Total operating expense   3,780,705   5,592,319   7,711,845     48,437,789   Operating loss (474,844) (2,250,041) (1,571,774) (42,378,313)   Other expense Other expense - 17,244 14,872 18,167 Interest expense   143,485   139,875   227,526   298,864   Total other expense   143,485   157,119   242,398   317,031   Loss before income taxes (618,329) (2,407,160) (1,814,172) (42,695,344) Income tax expense   -   -   -   600,000   Net loss (618,329) (2,407,160) (1,814,172) (43,295,344)   Preferred stock dividend   93,000   -   174,633   - Net loss attributible to common stockholders $ (711,329) $ (2,407,160) $ (1,988,805) $ (43,295,344)   Net loss per share: Basic and Diluted $ (0.05) $ (0.21) $ (0.16) $ (3.87)   Weighted average shares: Basic and Diluted 12,946,802 11,207,021 12,739,201 11,184,348      

Luna Innovations Incorporated Consolidated Balance Sheets

   

June 30,

December 31,

2010

2009

Assets (unaudited) Current assets Cash and cash equivalents $ 6,267,969 $ 5,228,802 Accounts receivable, net 8,044,870 7,203,203 Inventory, net 2,971,791 2,890,364 Prepaid expenses 576,095 560,964 Other current assets   45,530   729,532   Total current assets 17,906,255 16,612,865 Property and equipment, net 3,678,257 4,129,015 Intangible assets, net 557,829 580,785 Other assets   362,007   435,259   Total assets $ 22,504,348 $ 21,757,924   Liabilities and stockholders’ equity (deficit) Liabilities not subject to compromise: Current Liabilities: Line of Credit 2,500,000 - Current portion of long term-debt obligation 1,296,867 - Accounts payable 2,187,396 1,142,267 Accrued liabilities 3,278,705 3,386,849 Deferred credits   1,453,460   1,027,016   Total current liabilities 10,716,428 5,556,132 Long-term debt obligation 3,271,696 - Liabilities subject to compromise   -   19,062,000   Total liabilities 13,988,124 24,618,132 Commitments and contingencies Stockholders’ equity (deficit): Preferred stock, par value $0.001,1,321,514 shares authorized, issued and outstanding at June 30, 2010 1,322 - Common stock, par value $0.001, 100,000,000 shares authorized, 13,119,866 and 11,351,967 shares issued and outstanding at June 30, 2010 and December 31, 2009, respectively 13,199 11,352 Additional paid-in capital 54,590,767 41,228,698 Accumulated deficit   (46,089,064)   (44,100,258)   Total stockholders’ equity (deficit)   8,516,224   (2,860,208)   Total liabilities and stockholders’ equity (deficit) $ 22,504,348 $ 21,757,924      

Luna Innovations Incorporated Consolidated Statements of Cash Flows

  Six months ended June 30, 2010 2009 (unaudited) Cash flows used in operating activities Net loss $ (1,814,172) $ (43,295,344) Adjustments to reconcile net loss to net cash used in operating activities Depreciation and amortization 641,979 1,142,846 Impairment of intangible assets - 1,310,598 Stock-based compensation 1,763,015 1,569,043 Deferred tax expense - 600,000 Change in assets and liabilities: Accounts receivable (1,007,451) 452,114 Inventory (127,163) (22,590) Other current assets 668,871 - Other assets 31,024 (60,071) Accounts payable and accrued expenses (2,264,121) (559,125) Litigation reserve - 36,303,643 Deferred credits   426,444   11,967   Net cash used in operating activities   (1,681,574)   (2,546,919)   Cash flows used in investing activities Acquisition of property and equipment (39,146) (41,445) Intangible property costs   (88,712)   (121,132)   Net cash used in investing activities   (127,858)   (162,577)   Cash flows provided by (used in) financing activities Payments on capital lease obligations (2,684) (5,614) Proceeds from debt obligations 2,500,000 - Payment of debt obligations (265,657) (714,285) Proceeds from the exercise of options and warrants   616,940   20,693   Net cash provided by (used in) financing activities   2,848,599   (699,206)   Net change in cash 1,039,167 (3,408,702) Cash and cash equivalents—beginning of period   5,228,802   15,518,960   Cash and cash equivalents—end of period $ 6,267,969 $ 12,110,258          

Luna Innovations Incorporated Reconciliation of EBITDA and Adjusted EBITDA to Net Income/ (Loss)

  Three Months Ended Six Months Ended

June 30,

June 30, 2010 2009 2010 2009 (unaudited) (unaudited) Reconciliation of net loss to adjusted EBITDA less litigation and reorganization-related items   Net loss $ (618,329 ) $ (2,407,160 ) $ (1,814,172 ) $ (43,295,344 )   Interest 143,485 139,877 227,526 298,864 Taxes - - - 600,000 Depreciation and amortization 313,020 523,055 641,979 1,142,843 Impairment of intangible assets   -     -     -     1,310,598   EBITDA (161,824 ) (1,744,228 ) (944,667 ) (39,943,039 )   Stock-based compensation 875,675 779,518 1,764,015 1,569,029 Warrant expense 75,139 - 122,183 - Litigation reserve - - - 36,303,643

Fees associated with litigation and reorganization

  39,863     1,465,752     422,750     2,256,133   Adjusted EBITDA less litigation and reorganization-related items $ 828,853   $ 501,042   $ 1,364,281   $ 185,766